KUALA LUMPUR: The Pfizer-BioNtech vaccine, the first Covid-19 vaccine to be given conditional registration approval by the Drug Control Authority (DCA) and the National Pharmaceutical Regulatory Agency (NPRA), went through the proper evaluation process and its use will be closely monitored.

Health director-general Tan Sri Dr Noor Hisham Abdullah said the vaccine, produced by Pfizer-BioNTech, Comirnaty Concentrate for Dispersion For Injection was approved on Jan 8 this year.